Combination nivolumab- and cabiralizumab-associated acute bilateral anterior and posterior scleritis and anterior uveitis

American Journal of Ophthalmology Case Reports

Volumn 10, Issue , 2018, Pages 117-118

  Gonzales, John A ^a,b   Shantha, Jessica ^a,b   Acharya, Nisha R ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cabiralizumab; Cancer immunotherapy; Nivolumab; Scleritis; Side effects; Uveitis

Indexed keywords

CABIRALIZUMAB; FPA 008; NIVOLUMAB; PREDNISOLONE ACETATE; PREDNISONE;

AFFERENT PUPILLARY DEFECT; AGED; ARTICLE; B SCAN; CANCER IMMUNOTHERAPY; CASE REPORT; CAUCASIAN; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DRUG DOSE REDUCTION; EYE PAIN; HUMAN; INTRAOCULAR PRESSURE; IRIDOCYCLITIS; MALE; MEDICAL HISTORY; OPHTHALMOSCOPY; PERIORBITAL EDEMA; POSTERIOR SCLERITIS; SCLERITIS; SLIT LAMP MICROSCOPY; SPECTACLE CORRECTED VISUAL ACUITY; VISUAL ACUITY;

EID: 85044448400     PISSN: 24519936     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajoc.2018.02.005     Document Type: Article

References (5)

1. Topalian, S.L., Hodi, F.S., Brahmer, J.R., et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med 366:26 (2012), 2443–2454.
2. Abu Samra, K., Valdes-Navarro, M., Lee, S., Swan, R., Foster, C.S., Anesi, S.D., A case of bilateral uveitis and papillitis in a patient treated with pembrolizumab. Eur J Ophthalmol 26:3 (2016), e46–48.
3. Basilious, A., Lloyd, J.C., Posterior subcapsular cataracts and hypotony secondary to severe pembrolizumab induced uveitis: case report. Can J Ophthalmol 51:1 (2016), e4–6.
4. Hanna, K.S., A rare case of pembrolizumab-induced uveitis in a patient with metastatic melanoma. Pharmacotherapy 36:11 (2016), e183–e188.
5. Karlin, J., Gentzler, R., Golen, J., Bilateral anterior uveitis associated with nivolumab therapy. Ocul Immunol Inflamm, 2016, 1–3.